114 related articles for article (PubMed ID: 10731914)
1. Uterine artery Doppler velocimetry in the prediction of adverse obstetric outcomes in unexplained MSAFP elevations.
Chung JE; Cho JS; Han SS; Park YW; Kim JW
Yonsei Med J; 2000 Feb; 41(1):17-21. PubMed ID: 10731914
[TBL] [Abstract][Full Text] [Related]
2. Uterine artery Doppler velocimetry in the detection of adverse obstetric outcomes in women with unexplained elevated maternal serum alpha-fetoprotein levels.
Konchak PS; Bernstein IM; Capeless EL
Am J Obstet Gynecol; 1995 Oct; 173(4):1115-9. PubMed ID: 7485303
[TBL] [Abstract][Full Text] [Related]
3. Relationship between second trimester maternal serum alpha-fetoprotein and umbilical artery Doppler velocimetry and their association with preterm delivery.
Weiner CP; Grant SS; Williamson RA
Am J Perinatol; 1991 Jul; 8(4):263-8. PubMed ID: 1720619
[TBL] [Abstract][Full Text] [Related]
4. Uterine artery Doppler velocimetry for the detection of adverse obstetric outcomes in patients with elevated mid-trimester beta-human chorionic gonadotrophin.
Barkehall-Thomas A; Wilson C; Baker L; ni Bhuinneain M; Wallace EM
Acta Obstet Gynecol Scand; 2005 Aug; 84(8):743-7. PubMed ID: 16026398
[TBL] [Abstract][Full Text] [Related]
5. Prediction of preeclampsia or intrauterine growth restriction by second trimester serum screening and uterine Doppler velocimetry.
Audibert F; Benchimol Y; Benattar C; Champagne C; Frydman R
Fetal Diagn Ther; 2005; 20(1):48-53. PubMed ID: 15608460
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound detection of placental insufficiency in women with elevated second trimester serum alpha-fetoprotein or human chorionic gonadotropin.
Toal M; Chaddha V; Windrim R; Kingdom J
J Obstet Gynaecol Can; 2008 Mar; 30(3):198-206. PubMed ID: 18364097
[TBL] [Abstract][Full Text] [Related]
7. Predicting pregnancy outcome from the degree of maternal serum alpha-fetoprotein elevation.
Cusick W; Rodis JF; Vintzileos AM; Albini SM; McMahon M; Campbell WA
J Reprod Med; 1996 May; 41(5):327-32. PubMed ID: 8725757
[TBL] [Abstract][Full Text] [Related]
8. Prediction of smallness for gestational age by maternal serum human chorionic gonadotropin levels and by uterine artery Doppler study.
Miyakoshi K; Tanaka M; Gabionza D; Ishimoto H; Miyazaki T; Yoshimura Y
Fetal Diagn Ther; 2001; 16(1):42-6. PubMed ID: 11125251
[TBL] [Abstract][Full Text] [Related]
9. Doppler velocimetry of the umbilical artery as a predictor of pregnancy outcome in pregnancies characterized by elevated maternal serum alpha-fetoprotein and normal amniotic fluid alpha-fetoprotein.
Jaffa A; Yaron Y; Har-Toov J; Amster R; Legum C; Lessing JB
Fetal Diagn Ther; 1997; 12(2):85-8. PubMed ID: 9218947
[TBL] [Abstract][Full Text] [Related]
10. Twin pregnancies in the second trimester in women in an alpha-fetoprotein screening program: sonographic evaluation and outcome.
Pretorius DH; Budorick NE; Scioscia AL; Krabbe JK; Ko S; Myhre CM
AJR Am J Roentgenol; 1993 Nov; 161(5):1007-13. PubMed ID: 7506005
[TBL] [Abstract][Full Text] [Related]
11. The relationship between unexplained elevated serum markers in triple test, uterine artery Doppler measurements and adverse pregnancy outcome.
Karsidag AY; Buyukbayrak EE; Kars B; Suyugul U; Unal O; Turan MC
J Pak Med Assoc; 2010 Mar; 60(3):181-6. PubMed ID: 20225773
[TBL] [Abstract][Full Text] [Related]
12. Low birth weight and preterm delivery in relation to early-gestation vaginal bleeding and elevated maternal serum alpha-fetoprotein.
Williams MA; Hickok DE; Zingheim RW; Mittendorf R; Kimelman J; Mahony BS
Obstet Gynecol; 1992 Nov; 80(5):745-9. PubMed ID: 1383900
[TBL] [Abstract][Full Text] [Related]
13. Unexplained elevations of maternal serum alpha-fetoprotein in women with antiphospholipid antibodies: a harbinger of fetal death.
Silver RM; Draper ML; Byrne JL; Ashwood EA; Lyon JL; Branch DW
Obstet Gynecol; 1994 Jan; 83(1):150-5. PubMed ID: 7505912
[TBL] [Abstract][Full Text] [Related]
14. The clinical value of combining maternal serum screening and uterine artery Doppler in prediction of adverse pregnancy outcome.
Elsandabesee D; Srinivas M; Kodakkattil S
J Obstet Gynaecol; 2006 Feb; 26(2):115-7. PubMed ID: 16483965
[TBL] [Abstract][Full Text] [Related]
15. Second-trimester prediction of severe placental complications in women with combined elevations in alpha-fetoprotein and human chorionic gonadotrophin.
Alkazaleh F; Chaddha V; Viero S; Malik A; Anastasiades C; Sroka H; Chitayat D; Toi A; Windrim RC; Kingdom JC
Am J Obstet Gynecol; 2006 Mar; 194(3):821-7. PubMed ID: 16522419
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
17. Unexplained elevation in maternal serum alpha-fetoprotein and subsequent fetal loss.
Maher JE; Davis RO; Goldenberg RL; Boots LR; DuBard MB
Obstet Gynecol; 1994 Jan; 83(1):138-41. PubMed ID: 7505911
[TBL] [Abstract][Full Text] [Related]
18. Elevated maternal serum alpha-fetoprotein: association with placental sonolucencies, fetomaternal hemorrhage, vaginal bleeding, and pregnancy outcome in the absence of fetal anomalies.
Bernstein IM; Barth RA; Miller R; Capeless EL
Obstet Gynecol; 1992 Jan; 79(1):71-4. PubMed ID: 1370124
[TBL] [Abstract][Full Text] [Related]
19. Second-trimester maternal serum alpha-fetoprotein elevation and its association with adverse maternal/fetal outcome: ten years experience.
Anfuso S; Soncini E; Bonelli P; Piantelli G; Gramellini D
Acta Biomed; 2007 Dec; 78(3):214-9. PubMed ID: 18330082
[TBL] [Abstract][Full Text] [Related]
20. Maternal serum human chorionic gonadotropin as a marker for the delivery of low-birth-weight infants in women with unexplained elevations in maternal serum alpha-fetoprotein.
Hurley TJ; Miller C; O'Brien TJ; Blacklaw M; Quirk JG
J Matern Fetal Med; 1996; 5(6):340-4. PubMed ID: 8972411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
